Docgo (DCGO) Stock
Mobile healthcare provider delivering home care and patient transport. Here's the price, business snapshot, and what's worth knowing about Docgo in November 2026.
DOCGO Inc (DCGO) operates in the US healthcare services market, providing mobile, in-home and virtual medical services alongside non-emergency patient transport. With a market capitalisation of about $145.7 million, the company mixes technology-enabled care delivery with local operations and partnerships to reach patients outside traditional clinical settings. Investors typically watch DOCGO for revenue growth potential tied to expanding service lines, geographic reach and telehealth adoption, but the business can be sensitive to reimbursement rules, regulatory change and integration challenges as it scales. Smaller-cap stocks like DCGO tend to be more volatile and less liquid than larger peers, so price swings can be greater. This summary is for general education only and does not constitute investment advice. Prospective investors should review the company’s filings, recent results and sector dynamics, and consider how a speculative, smaller-cap healthcare services stock would fit their personal risk tolerance and portfolio goals.
Docgo (DCGO) Stock Forecast
Analyst price target, next 12 months
$5.33
+2060.1% vs today's $0.25
Price range over the last 12 months
Close to its 12-month low
Analysts covering Docgo have a consensus 12-month target of $5.33, above the current price of $0.25.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 17 Jul 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying DOCGO's stock with a target price of $5.33, indicating significant growth potential.
Financial Health
DOCGO INC is performing well with solid revenue and cash flow, indicating a strong financial position.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring DCGO
The GLP-1 Insurance Gap Reshaping Weight Care in 2026
Cigna's decision to drop coverage for popular GLP-1 weight-loss drugs like Wegovy and Zepbound for its employees signals a potential shift in employer-sponsored healthcare. This policy change could drive significant demand toward affordable direct-to-consumer telehealth platforms and alternative digital weight management programs.
Published: 3 June 2026
Explore BasketAt-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: 30 August 2025
Explore BasketWhy You’ll Want to Watch This Stock
Mobile Care Growth
Rising demand for out-of-hospital care and telehealth could support revenue growth, though execution and payer dynamics matter and outcomes can vary.
Expanding Service Footprint
Geographic expansion and partnerships may broaden reach and scale, but expansion brings integration and regulatory risks to monitor.
Operational Efficiency Focus
Improving operational efficiency and reimbursement management can boost margins, yet small-cap volatility and policy changes can affect results.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
